1. Effects of bacteria-mediated reprogramming and antibiotic pretreatment on the course of colitis in mice
    ROMAN GARDLIK et al, 2014, Molecular Medicine Reports CrossRef
  2. Recent advances in bacteria‐based platforms for inflammatory bowel diseases treatment
    Jiaoying Lu et al, 2024, Exploration CrossRef
  3. Angiogenesis in Inflammatory Bowel Disease
    Canan Alkim et al, 2015, International Journal of Inflammation CrossRef
  4. Combining DNA Vaccine and AIDA-1 in AttenuatedSalmonellaActivates Tumor-Specific CD4+ and CD8+ T-cell Responses
    Yu Mei et al, 2017, Cancer Immunology Research CrossRef
  5. In vivo reprogramming in inflammatory bowel disease
    A Wagnerova et al, 2013, Gene Therapy CrossRef
  6. Vaccination therapy for inflammatory bowel disease
    Yafei Liu et al, 2023, Human Vaccines & Immunotherapeutics CrossRef
  7. Pathological and therapeutic interactions between bacteriophages, microbes and the host in inflammatory bowel disease
    Janka Babickova, 2015, World Journal of Gastroenterology CrossRef
  8. Beneficial effects of live and dead Salmonella -based vector strain on the course of colitis in mice
    A. Wagnerova et al, 2016, Letters in Applied Microbiology CrossRef
  9. Colonic gene silencing using siRNA-loaded calcium phosphate/PLGA nanoparticles ameliorates intestinal inflammation in vivo
    Annika Frede et al, 2016, Journal of Controlled Release CrossRef
  10. Investigate the genetic mechanisms of diabetic kidney disease complicated with inflammatory bowel disease through data mining and bioinformatic analysis
    Xiaoyu Zhang et al, 2023, Frontiers in Endocrinology CrossRef
  11. Advances in therapeutic interventions targeting the vascular and lymphatic endothelium in inflammatory bowel disease
    Silvia D’Alessio et al, 2013, Current Opinion in Gastroenterology CrossRef
  12. Bioengineered and biohybrid bacteria-based systems for drug delivery
    Zeinab Hosseinidoust et al, 2016, Advanced Drug Delivery Reviews CrossRef
  13. Placental growth factor enhances angiogenesis in human intestinal microvascular endothelial cells via PI3K/Akt pathway: Potential implications of inflammation bowel disease
    Yi Zhou et al, 2016, Biochemical and Biophysical Research Communications CrossRef